Home

текст комбайн данни nature medicine crispr пръстови отпечатъци Нищо Актуализация

Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine

First CRISPR editing trial results assuage safety concerns
First CRISPR editing trial results assuage safety concerns

Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Nature Medicine》基因编辑工具增加致癌隐患- 生物通

CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine

CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology

The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

Focus on CRISPR tools and therapies | Nature Biotechnology
Focus on CRISPR tools and therapies | Nature Biotechnology

Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL

Is Crispr the Next Antibiotic? - The New York Times
Is Crispr the Next Antibiotic? - The New York Times

Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online

CRISPR-Cas 9 corrects genetic defects in mice
CRISPR-Cas 9 corrects genetic defects in mice

CRISPR: gene editing is just the beginning : Nature News & Comment
CRISPR: gene editing is just the beginning : Nature News & Comment

CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American

Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine

The kill-switch for CRISPR that could make gene-editing safer
The kill-switch for CRISPR that could make gene-editing safer

Untangling the CRISPR cancer scare
Untangling the CRISPR cancer scare

Super-precise new CRISPR tool could tackle a plethora of genetic diseases
Super-precise new CRISPR tool could tackle a plethora of genetic diseases

CRISPR algorithm predicts how well gene editing will work - Scope
CRISPR algorithm predicts how well gene editing will work - Scope

Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"

Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries

CRISPR, one of the biggest science stories of the decade, explained - Vox
CRISPR, one of the biggest science stories of the decade, explained - Vox

A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog